Ellen Vitetta, Ph.D.

Medical School

New York University , Medicine

Graduate School

New York Medical College (1966)

Graduate School

New York Medical College (1968)

• Antibody-based therapies
• Cancer Dormancy
• Nanotechnology
• Vaccines

Featured Publications

Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis.

Soliman SSM, Baldin C, Gu Y, Singh S, Gebremariam T, Swidergall M, Alqarihi A, Youssef EG, Alkhazraji S, Pikoulas A, Perske C, Venkataramani V, Rich A, Bruno VM, Hotopp JD, Mantis NJ, Edwards JE, Filler SG, Chamilos G, Vitetta ES, Ibrahim AS, Nat Microbiol 2021 Jan

Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.

Pincus SH, Song K, Maresh GA, Hamer DH, Dimitrov DS, Chen W, Zhang MY, Ghetie VF, Chan-Hui PY, Robinson JE, Vitetta ES J. Virol. 2016 Nov

The immunogenicity of peptoid-protein conjugates: Implications for a new vaccine discovery platform,

Allison Case, Angela Desmond, Daniel Lopes, Kelly Dye, Jiyeun Kate Kim, Pavitra Chakravarty, Laurentiu M.Pop, Joan E. Smallshaw and Ellen S.Vitetta. J. Vaccines and Vaccinology 2016 329 10.4172 7 2157-7560

A reevaluation of CD22 expression in human lung cancer.

Pop LM, Barman S, Shao C, Poe JC, Venturi GM, Shelton JM, Pop IV, Gerber DE, Girard L, Liu XY, Behrens C, Rodriguez-Canales J, Liu H, Wistuba II, Richardson JA, Minna JD, Tedder TF, Vitetta ES Cancer Res. 2014 Jan 74 1 263-71

Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines.

Liu XY, Pop LM, Tsai L, Pop IV, Vitetta ES Int. J. Cancer 2011 Jul 129 2 497-506

Specific thermal ablation of tumor cells using single-walled carbon nanotubes targeted by covalently-coupled monoclonal antibodies.

Marches R, Chakravarty P, Musselman IH, Bajaj P, Azad RN, Pantano P, Draper RK, Vitetta ES Int. J. Cancer 2009 Dec 125 12 2970-7

A phase 1 study of Combotox in pediatric patients with refractory B-lineage acute lymphoblastic leukemia.

Herrera L, Bostrom B, Gore L, Sandler E, Lew G, Schlegel PG, Aquino V, Ghetie V, Vitetta ES, Schindler J J. Pediatr. Hematol. Oncol. 2009 Dec 31 12 936-41

RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol

Smallshaw, J.E., Richardson, J.A., and Vitetta, E.S Vaccine 2007 25 7459=7469

Generation and characterization of a novel tetravalent anti-CD22 antibody with improved antitumor activity and pharmacokinetics

Liu, X., Pop, L., Smallshaw, J.E., Ghetie, V., Vitetta, E.S Int Immunopharma 2006 6:5 791-799

• Minnie Piper Professorship
  Election (2011)
• Texas Regents Teaching Academy
  Election (2011)
• American Association of Immunologists
  Lifetime Achievement Award (2007)
• Texas Women’s Hall of Fame
  Award (2007)
• UT Southwestern Basic Science Educator Award
  Election (2007)
• Distinguished Teaching Professor
  Appointed (2006)
• National Academy of Medicine
  Election (2006)
• Shine Academy of Teachers
  Election (2006)
• Alpha Omega Alpha
  Election (2004)
• American Association of Cancer Research
  Charlotte Friend Award (2002)
• American Association of Immunologists
  Mentoring Award (2002)
• American Academy of Microbiology
  Election (1997)
• American Association of Cancer Research
  Rosenthal Award (1995)
• American Association of Immunologists
  President (election) (1994)
• National Academy of Sciences
  Election (1994)
• FASEB Excellence in Science Award
  Award (1991)

• Academy of Cancer Immunology
• American Academy of Arts and Sciences
• American Assocation of Immunologists
• American Association of Cancer Research
• American Women in Science